Filing Details
- Accession Number:
- 0001384101-21-000155
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-09 17:07:35
- Reporting Period:
- 2021-09-07
- Accepted Time:
- 2021-09-09 17:07:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1769333 | C Giulia Kennedy | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | Chief Scientific & Med Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-07 | 4,406 | $5.98 | 55,381 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-09-07 | 3,750 | $20.21 | 59,131 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-09-07 | 4,375 | $24.69 | 63,506 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-07 | 12,034 | $50.52 | 51,472 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-07 | 497 | $51.23 | 50,975 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-08 | 926 | $50.53 | 50,049 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-09-07 | 4,406 | $0.00 | 4,406 | $5.98 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-09-07 | 3,750 | $0.00 | 3,750 | $20.21 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-09-07 | 4,375 | $0.00 | 4,375 | $24.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,813 | 2028-03-01 | No | 4 | M | Direct | |
| 22,500 | 2029-02-27 | No | 4 | M | Direct | |
| 43,750 | 2030-03-27 | No | 4 | M | Direct |
Footnotes
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021.
- Represents weighted average sales price. Sale prices for the transactions range from $50.06 to $51.06. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- Represents weighted average sales price. Sale prices for the transactions range from $51.07 to $51.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
- The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
- The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
Billionaire Hedge Funds
